Preclinical study of artificial red cells ; Neo Rgl Cells
Preclinical study of artificial red cells ; Neo Rgl Cells
批准号:
05454359
负责人:
USUBA Akira
金额:
$3.52万
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1993
资助国家:
日本
项目状态:
已结题
起止时间:
1993 至 1995
中文摘要
我们评价了脂质体包裹的HbNeo红细胞(NRC)对不可逆性失血性休克的影响。并作为部分和完全体外循环的灌流液。[失血性休克]方法:选用8只小猎犬,体重10~13 kg。以30毫升/分钟的速度从动脉中取出血液,以诱发失血性休克,使收缩压降至60毫米汞柱以下。稳态30分钟后,不作任何处理,以相同的速率输注NRC。这种更换重复了三次以上。为了维持良好的循环,动物需要1.5倍的NRC输血量才能失血。换血后,输注低粘度NRC(小于全血的1/3)时,心脏指数没有增加,血管阻力也没有降低。在这种情况下,NRC使氧转运效率从32.2%提高到43.1%,补偿了心输出量的减少,并贡献了…的增加更多地缓解了氧气消耗。另一方面,红细胞的OTE增加不超过15%,对周围组织的供氧也不满意。重度失血性休克时,即使输注低粘度NRC,血管阻力也不会降低,心输出量也不会增加。而NRC通过提高氧转运效率来补偿心输出量的减少,满足氧需求。[部分体外循环(PCPB)]成年杂种犬10只,体重9~11 kg,37℃,用滚柱泵进行非搏动性体外循环。NRC组6只,灌流液为NRC 500ml、羟乙基淀粉500ml、L美隆40ml、甘露醇3ml/kg(20%)。对照组4只,灌流液为羟乙基淀粉1000ml、L美龙40ml、甘露醇3ml/kg(20%)。PCPB持续数小时。NRC组血管阻力(RV)下降幅度小于对照组的1/4。这一变化表明,其粘度低于红细胞(RBC)。NRC的供氧量是RBC的两倍以上,降低了血管阻力,增加了心输出量,表现出良好的氧输送能力。NRC适合作为两种PCPB的灌流液。[全心肺转流(TCPB)]TCPB在57.1-73.3%的自体血清除后开始,持续7h。在使用NRC的TCPB中,血管阻力(VR)降至使用红细胞(RBC)时的1/4。这一变化表明,粘度低于RBC的NRC减轻了循环系统的负荷。NRC输送的氧量高于RBC输送的氧量,导致NRC的耗氧量较大。在TCPB期间,血清LDH水平低于RBC。因此,NRC补偿了稀释式TCPB的不利之处--氧输送能力的降低,进一步增加了对流TCPB的循环,进一步改善了循环
英文摘要
We evaluated the effects of liposome encapsulated homoglobin Neo Red Cell (NRC) on irreversible homorrhagicshock. and as a perfusate for partial and total cardiopulmonary bypass. [Homorrhagic shock] Methods : Eight beagles (body weight ; 10-13kg) were used. Blood was removed from the arteries at a rate of 30 ml/min to induce hemorrhagic shockbringing the systolic pressure lower than to 60 mmHg. After 30 minutes steady state without any treatment NRC was transfused at the same rate. This replacement repeated more than three times. To maintained the circulation satisfactory, the animal needed the 1.5 times amount of NRC transfusion to blood loss. After blood exchange, the cardiac index did not increase and vascular resistance did not decrease in spite of low viscosity NRC (less than 1/3 of that of whole blood) transfusion. In this situation, NRC increased the oxygentransport efficiency (OTE) averaged from 32.2 to 43.1%, compensated the reduction of cardiac output and contributed the incr … More easing the oxygenconsumption. On the other hand, red blood cell did not increase the OTE more than 15% and did not supply oxygen to peripheral tissue satisfactory. On severe hemorrhagic shock, even if transfused low viscosity NRC,vascular resistance did not decrease and cardiac output did not increase. However, NRC compensated reduction of cardiac output by increasing its oxygen transport efficiency and satisfied the oxygen demand. [Partial cardiopulmonary bypass (PCPB)] Nonpulsatile PCPB was made in 10 adult mongrel dogs weighing 9-11 kg at 37 Cusing a rollerpump. The perfusate was 500ml NRC,500 ml hydroxyethylstarch (HES), 40 ml/L Meylon, AND 3 ml/kg mannitol (20%) on NRC group (6 animals). The perfusate was 1000 ml HES,40 ml/L Meylon, and 3 ml/kg mannitol (20%) on controlgroup (4 animals). PCPB was continued for hour. Vascular resistance (RV) in NRC group decreased less than 1/4 of VR in control group. This change suggests that, the viscosity of which is lower than that red blood cells (RBC). NRC delivered oxygen more than two times of that of RBC.NRC reduced vascular resistance, increased cardiac output, and showed excellentoxygen transport ability. NRC is suitable as perfusate for both PCPB.[Total cardiopulmonary bypass (TCPB)] The TCPB was started after removal of 57.1-73.3% of autologous blood and continued for 7 hours. During TCPB using NRC,the vascular resistance (VR) decreased to 1/4 of VR when red blood cells (RBC) were used. This change suggests that NRC,the viscosity of which is lower than that of RBC,reduced the load on the circulation system. The oxygen volume delivered by NRC was higher than that delivered by RBC,resulting in a greater oxygen consumption with NRC.During TCPB,the serum LDH level was lower than that using RBC.So we concluded that NRC compensated for the reduction in the oxygen transport ability, which is a disadvantage of dilution TCPB,and further increased the circulation of dijution TCPB,and further increased the circulation improvin Less
期刊论文(80)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
薄場 彰: "新しいパ-フルオロケミカル" 日常診療と血液. 4. 1613-1618 (1994)
Akira Usuba:“新全氟化学品”日常医疗和血液。4。1613-1618(1994)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
薄場 彰,元木良一: "人工血液の開発と展望" 日外傷会誌. 10. 4-12 (1996)
Akira Usuba、Ryoichi Motoki:“人工血液的发展和前景”日本创伤学杂志。10. 4-12 (1996)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
薄場 彰ほか: "NRCの課題-臨床治験を前にして" 人工臓器. 24. 201-205 (1995)
Akira Usuba 等人:“NRC 问题 - 临床试验前”人工器官。24. 201-205 (1995)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
A.Usuba,et al: "Effect of neo recl cells on hemodynamics and blood gas transport in canine hemoeehagic shock and its safety for vital organs" Art.Cells,Blood Subs.,And Immob.Biotech.22. 503-516 (1994)
A.Usuba 等人:“neo recl 细胞对犬失血性休克中血流动力学和血气运输的影响及其对重要器官的安全性”Art.Cells、Blood Subs. 和 Immob.Biotech.22。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Kenji Honda, Akira Usuba, et al: "Development of artificial blood:From Fluosal-DA(FDA)to Neo Red Cell(NRC)" Biomaterial-living System Interactions. 1. 77-84 (1993)
Kenji Honda、Akira Usuba 等人:“人造血液的开发:从 Fluosal-DA (FDA) 到 Neo Red Cell (NRC)”生物材料-生命系统相互作用。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 37 条